Portfolio Update

RNS Number : 6046X

Intl. Biotechnology Trust PLC

27 November 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 October 2017

Net Assets	£231m
Net Assets per share	616p
Share price	600p
Total value of unquoted investments	£21m
Total number of portfolio companies	90
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Biogen	7.3
Celgene	5.9
Regeneron	5.4
Vertex	4.2
Exelixis	3.6
Adamas	3.5
Incyte	3.3
Gilead	3.0
Alexion	3.0
Acadia	2.7
	-----------
Total	41.9

Geographical Allocation	% NAV
US & Canada	89
Europe & UK	11
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	41
Mid Cap =USD1-10BN	27
Small Cap <USD1BN	32
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	35
Rare diseases	13
CNS	12
Inflammation	9
Ophthalmology	8
Infectious Diseases	6
Metabolic	6
Medtech	2
Other	9
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

27 NOVEMBER 2017

 

END

 

 

PFUBBBDBBXDBGRR